News

  • 20 October 2011

    CSI Predator 360 systems found to effectively treat PAD

    Cardiovascular Systems' (CSI) Predator 360° prospective single-centre clinical study has demonstrated beneficial long-term durability of the Predator 360 PAD system in treating peripheral arterial disease (PAD), or blockages in leg...

  • 18 October 2011

    FDA approves PLC Systems to begin RenalGuard trial

    The US Food and Drug Administration (FDA) has granted approval for PLC Systems to initiate its US pivotal trial to study the efficacy of the company's RenalGuard Therapy and RenalGuard...

Close
Close
Close

Go Top